Enlivex Therapeutics
ENLV
ENLV
19 hedge funds and large institutions have $4.31M invested in Enlivex Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
12% more funds holding
Funds holding: 17 → 19 (+2)
1.99% more ownership
Funds ownership: 9.99% → 11.98% (+2%)
Holders
19
Holding in Top 10
–
Calls
$71K
Puts
$25K
Top Buyers
| 1 | +$737K | |
| 2 | +$50.4K | |
| 3 | +$5.38K | |
| 4 |
Renaissance Technologies
New York
|
+$5.21K |
| 5 |
S
SignatureFD
Atlanta,
Georgia
|
+$5.04K |